• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of clinical psychiatry >Depression and anxiety in oncology: the psychiatrist's perspective.
【24h】

Depression and anxiety in oncology: the psychiatrist's perspective.

机译：肿瘤科的抑郁症和焦虑症：精神科医生的观点。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Depression and anxiety are frequently undiagnosed and untreated in cancer patients, resulting in a significant negative impact on quality of life and disease outcome. Furthermore, although effective therapies for depression and anxiety are available, there have been few clinical trials of pharmacotherapy in cancer patients. This article explores how the diagnosis of depression and anxiety can be improved in cancer patients and reviews current treatment options in the oncology setting. The Hospital Anxiety and Depression Scale, a simple, patient-administered questionnaire, is effective in screening for psychiatric symptoms at an early stage of cancer treatment, particularly if vulnerable individuals can be identified and targeted. Selective serotonin reuptake inhibitors are currently first-choice therapy for depression, and many of the drugs in the class are effective in anxiety disorders. Further studies of these agents in the oncology setting are warranted.
机译：癌症患者经常无法诊断和治疗抑郁症和焦虑症，从而对生活质量和疾病结局产生重大负面影响。此外，尽管可获得用于抑郁和焦虑的有效疗法，但是在癌症患者中很少有药物疗法的临床试验。本文探讨了如何改善癌症患者的抑郁症和焦虑症的诊断，并综述了肿瘤学领域的当前治疗方案。医院焦虑和抑郁量表是一种简单的，由患者管理的问卷，可有效筛查癌症治疗早期的精神症状，尤其是在可以识别和确定易受攻击者的情况下。选择性5-羟色胺再摄取抑制剂目前是抑郁症的首选疗法，并且该类别中的许多药物都可有效治疗焦虑症。这些药物必须在肿瘤学领域进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号